He Wei-Wu 13D and 13G filings for CASI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-23 5:15 pm Purchase | 2021-11-18 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,598,199 17.470% | 438,000 (+20.28%) | Filing |
| 2021-02-03 4:01 pm Purchase | 2021-02-01 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 2,160,199 16.260% | 384,747 (+21.67%) | Filing |
| 2020-07-29 5:16 pm Purchase | 2020-07-24 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 1,775,452 13.780% | 520,900 (+41.52%) | Filing |
| 2020-03-24 4:01 pm Purchase | 2020-03-18 | 13D | CASI Pharmaceuticals, Inc. CASI | He Wei-Wu | 1,254,553 12.070% | 323,957 (+34.81%) | Filing |